Source comparison
Ipamorelin Cycle Length Protocol: Dosing & Duration Comparison
The table below compares three common ipamorelin cycle length protocols, detailing dose structure, cycle duration, off-cycle requirements, and expected GH response patterns based on receptor dynamics. | Protocol Type | Daily Dose & Frequency | Cycle Duration |
This comparison does not assign a generated winner or score.
- The table below compares three common ipamorelin cycle length protocols, detailing dose structure, cycle duration, off-cycle requirements, and expected GH response patterns based on receptor dynamics.
- | Protocol Type | Daily Dose & Frequency | Cycle Duration | Off-Cycle Duration | Mean GH Elevation | Receptor Downregulation Risk | Professional Assessment ||—|—|—|—|—|—|| Conservative (Once Daily) | 200–300mcg before bed | 8 weeks | 4 weeks | 25–30% above baseline | Low. Full receptor recovery between doses allows sustained response through 8 weeks | Best for first-time protocols or when prioritizing single robust nocturnal GH pulse || Standard (Twice Daily) | 150mcg morning + 150mcg pre-bed | 10–12 weeks | 6 weeks | 35–40% above baseline | Moderate. Partial receptor recovery between doses sustains response through 10 weeks with modest attenuation by week 12 | Optimal balance of sustained GH elevation and receptor longevity for most research applications || Intensive (Three Times Daily) | 100mcg doses spaced 6–8 hours | 6–8 weeks maximum | 8 weeks | 50–55% above baseline | High. Continuous receptor occupancy accelerates downregulation; pulse amplitude declines significantly after week